The DBEI distinctively brings together expertise in biostatistics, epidemiology and informatics, to advance population-health science.
Featured on DBEI
DBEI & CCEB 2022 Research Day: Check out our gallery of rising experts
From our biostatistics chief: COVID-19 commentaries, research results, models and more
In the News
Negative descriptors appear more often in clinical notes for Black patients — new findings that build on what we already know, says Nwamaka Eneanya, MD, MPH: “Such biases won't go anywhere without systemic interventions,” she comments.
How do we define “asymptomatic” COVID-19 cases? That can vary, says Michael David, MS, MD, PhD. Some patients have chronic respiratory symptoms as baseline, from congestive heart failure to allergies.
Amid the omicron surge, more patients are coming into the hospital for other reasons but testing positive for Covid-19 once they arrive. M. Kit Delgado, MD, MS, says that many now come with chronic conditions that normally are treated elsewhere — but now, because of the strain that the latest surge is placing on the system, hospitals are the only option available to them.
To understand health and disease today, we need new thinking and novel science —the kind we create when multiple disciplines work together from the ground up. That is why this department has put forward a bold vision in population-health science: a single academic home for biostatistics, epidemiology and informatics. LEARN MORE ABOUT US